AA
PRAX icon

ALPS Advisors’s Praxis Precision Medicines PRAX Stock Holding History

ALPS Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,424
Closed -$552K – 1068
2025
Q3 		$552K Sell
10,424
-570
-5% -$27.6K ﹤0.01% 650
2025
Q2 		$462K Sell
10,994
-3,944
-26% -$150K ﹤0.01% 656
2025
Q1 		$566K Sell
14,938
-128
-0.8% -$7.99K ﹤0.01% 575
2024
Q4 		$1.16M Buy
15,066
+1,637
+12% +$118K 0.01% 451
2024
Q3 		$773K Buy
13,429
+87
+0.7% +$4.7K 0.01% 556
2024
Q2 		$552K Buy
+13,342
New +$631K ﹤0.01% 561
2022
Q2 		– Sell
-3,116
Closed -$477K – 1080
2022
Q1 		$477K Sell
3,116
-344
-10% -$70.7K 0.01% 439
2021
Q4 		$1.02M Sell
3,460
-210
-6% -$61.6K 0.01% 353
2021
Q3 		$1.02M Sell
3,670
-160
-4% -$43.4K 0.01% 387
2021
Q2 		$1.05M Buy
+3,830
New +$1.37M 0.01% 398

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ALPS Advisors's PRAX Position: Q4 2025 in Review

ALPS Advisors sold out of Praxis Precision Medicines (PRAX) in Q4 2025, closing a stake of 10,424 shares — an estimated $552K sold.

ALPS Advisors first reported a position in PRAX in Q2 2021 and held it in 10 quarters. The position peaked at $1.16M in Q4 2024. 250 funds tracked by Wall St. Rank hold PRAX as of Q4 2025.

  • ALPS Advisors reported no remaining Praxis Precision Medicines position as of Q4 2025 after selling out during the quarter.
  • ALPS Advisors sold 10,424 Praxis Precision Medicines shares in Q4 2025, an estimated $552K.
  • ALPS Advisors first reported a position in Praxis Precision Medicines in Q2 2021 and held it in 10 quarters.
  • ALPS Advisors's Praxis Precision Medicines position peaked at $1.16M in Q4 2024.
  • 250 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2025.

Based on ALPS Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.